Page 13 - Biological E News Today

Read more about Govt to reserve 300 mn doses of Biological-E vaccine for August-December on Business Standard. The formulation, an RBD protein sub-unit vaccine, is currently undergoing Phase-3 trials

For this purpose, the Ministry of Health would be making an advance payment of ₹1,500 crore. The vaccine of Biological-E was currently undergoing Phase-3 clinical trial after it showed promising results in Phase 1 and 2 clinical trials. The RBD protein sub-unit vaccine is likely to be available in the next few months. “The proposal of M/s Biological-E was examined and recommended for approval after due diligence by National Expert Group on Vaccine Administration for COVID-19 (NEGVAC),” th...

The vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry said in a statement.

The RBD protein sub-unit vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry said in a statement.

Synopsis So far, only about 4.7% of the 950 million adult population have been given two vaccine doses as the worlds second-most populous country reels from a devastating second wave of infections that killed around 170,000 people in April and May alone. Reuters India signed its first order for an unapproved COVID-19 vaccine on Thursday, a day after it faced criticism from the Supreme Court over its bungled vaccine rollout that has left millions of people vulnerable after almost 338,000 deaths....

The central government has paid advance to local firm Biological-E even though its vaccine is still undergoing phase-3 clinical trials

A look at the biggest Covid-19 developments of the day.

NEW DELHI — In another landmark move in the fight against Covid-19 pandemic, the Central government has booked 300 million doses of another Made-in-India vaccine to be manufactured by Hyderabad-based Biological-Es Covid vaccine, which is still in final phase of clinical trials. Biological-Es vaccine is currently in Phase-3 clinical trials after showing promising results in Phase 1 and 2, and it is likely to be available in the market in next few months, said a Ministry of Health and Fam...

The vaccines will be manufactured and stockpiled by Biological-E from August-December 2021

भारत से कोरोना वायरस की दूसरी लहर का प्रकोप भले ही कम हो रहा हो लेकिन टीकाकरण की गति अब भी Government booked 30 crore doses corona vaccine from Biological-E will give 1500 crore rupees, Hindi News - Hindustan